Great review. It is important to remember if Brilacidin is successful against Covid 19 it will be a big boost to the rest of IPIX's future studies. It will allow funding of multiple trials without dilution. As you stated:

" Funding and revenue generated from B-CV19 will also allow the advancement on targeted areas of need that were the main focus of IPIX prior to the CV19 pandemic including B-OM and the enormous opportunity of B-IBD UC and Kevetrin advancement. "

GLTA Farrell